Author: Clemons Traci E. Gillies Marc C. Chew Emily Y. Bird Alan C. Peto Tunde Figueroa Maria J. Harrington Molly W.
Publisher: Informa Healthcare
ISSN: 0928-6586
Source: Ophthalmic Epidemiology, Vol.17, Iss.1, 2010-02, pp. : 66-73
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
How Prevalent is Macular Telangiectasia Type 2?
Ophthalmic Epidemiology, Vol. 19, Iss. 4, 2012-08 ,pp. :
Unusual Presentations of Type 2 Idiopathic Macular Telangiectasia
Ophthalmologica, Vol. 230, Iss. 3, 2013-08 ,pp. :
Intravitreal Bevacizumab for Type 2 Idiopathic Macular Telangiectasia
Ophthalmic Research, Vol. 49, Iss. 4, 2013-01 ,pp. :
By Christy Beula Keeffe Jill E. Nirmalan Praveen K. Rao Gullapalli N.
Ophthalmic Epidemiology, Vol. 17, Iss. 4, 2010-08 ,pp. :